Category: New products
-
Fraunhofer USA Gets FDA Go-Ahead for H5N1 Vaccine Trial
Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, Delaware says it received approval from the U.S. Food and Drug Administration (FDA) to proceed with the first human clinical trial of its plant-produced H5N1 influenza — avian flu — vaccine. The research institute filed an Investigational New Drug Application for its plant-derived H5N1 vaccine with…
-
Univ. Spinoff Tests Non-Chemical Device for Head Lice
Larada Sciences, a company started by faculty at University of Utah in Salt Lake City, released results of its LouseBuster device that removes head lice and their eggs from children’s hair without pesticides or other chemicals. The company says results of the test will be published in the January 2011 issue of the Journal of…
-
GE Demonstrates Prototype Hybrid-Battery Bus
GE Global Research, the technology development arm of General Electric Company, says it demonstrated a prototype transit bus with a hybrid battery — “hybrid” in this case means two different battery technologies to optimize power and storage. The company says the new type of battery can help electrify other larger, heavy-duty vehicles such as delivery…
-
Academics, Company Develop High-Performance Nanotech Fiber
Researchers at Northwestern University in Evanston, Illinois and MER Corporation in Tucson, Arizona have engineered a new kind of fiber that can absorb more energy than Kevlar, a fabric now woven into bulletproof vests and other industrial applications. MER — short for Materials and Electrochemical Research — Corporation develops high-tech materials, including those based on…
-
Mathematical Patterns Found to Forecast Spanish Earthquakes
Researchers in Spain have found patterns of tectonic behavior that occur before an earthquake on the Iberian peninsula. The team, from University of Seville and Pablo de Olavide University in Seville used mathematical clustering techniques to forecast medium to large seismic movements when certain conditions coincide. The research will be published this month by the…
-
Radar in Shoes Can Step In When GPS Fails
A global positioning system (GPS) is handy if you’re in a location where the device can access the positioning satellite, but at other times, such as in a building or underground, it doesn’t do much good. An engineering team at North Carolina State University (NCSU) in Raleigh and Carnegie Mellon University (CMU) in Pittsburgh, Pennsylvania…
-
Clinical Data Reported on Parkinson’s Biomarker Candidates
KineMed Inc., a drug discovery company in Emeryville, California says it recently presented data on a new use of cerebrospinal fluid biomarkers for the monitoring of disease progression and therapeutic interventions in Parkinson’s disease. The company reported the findings at a grant review meeting of the Michael J. Fox Foundation on 1 November 2010 in…
-
Trial Shows Drug Effect on ALS Blood Biomarker
Neuraltus Pharmaceuticals in Palo Alto, California said today an early stage clinical trial of its drug NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) showed improvement in a blood biomarker associated with the disease with patients taking the drug. ALS is a disease of the nerve cells in the brain…
-
New Process Replaces Toxic Substances to Make Nanomaterials
A study by a University of Missouri research team in Columbia has found a method that could replace nearly all of the toxic chemicals required to make gold nanoparticles. The ingredient to replace these toxic substances can be found in nearly every kitchen’s spice cabinet: cinnamon. And the researchers found their discovery could help in…
-
Nanomaterial Developed to Detect Excessive Blast Exposure
Investigators at the University of Pennsylvania School of Medicine and School of Engineering and Applied Sciences in Philadelphia have developed a color-changing patch that could be worn by military service members to indicate the strength of exposure to blasts from explosives in the field. The findings are described in the online edition of the journal…